HALOZYME THERAPEUTICS INC shareholders Q2 2023

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
XTX Topco Ltd 6,554$236,4030.04%
Dynamic Technology Lab Private Ltd 9,152$3300.04%
COLONY GROUP LLC 80,382$2,8990.04%
Point72 Asset Management, L.P. 379,560$13,690,7290.04%
MetLife Investment Management, LLC 146,791$5,294,7510.04%
TEXAS PERMANENT SCHOOL FUND CORP 115,942$4,182,0280.04%
Congress Wealth Management LLC / DE / 45,034$1,624,3740.04%
MGO ONE SEVEN LLC 11,657$420,4680.04%
Inspire Investing, LLC 8,659$312,3300.04%
E Fund Management Co., Ltd. 13,152$4740.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,800$1,543,7960.04%
Ergoteles LLC 21,664$781,4200.04%
Cerity Partners LLC 258,121$9,310,4250.04%
B. Metzler seel. Sohn & Co. AG 70,508$2,543,2240.03%
ClariVest Asset Management LLC 18,281$6600.03%
South Dakota Investment Council 43,326$1,5630.03%
Advisors Asset Management, Inc. 45,311$1,634,3680.03%
MILLENNIUM MANAGEMENT LLC 1,809,809$65,279,8110.03%
Leucadia National 98,000$3,534,8600.03%
Louisiana State Employees Retirement System 38,500$1,388,6950.03%
External links

This page lists HALOZYME THERAPEUTICS INC's shareholders in Q2 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.